Starting a Cannabis Business in France

Licensing

Required

Foreign Ownership

Allowed

Timeline

1-3 months for CBD retail

Business Types

CBD RetailHemp Cultivation & ProcessingMedical Cannabis (Experimental Program)

Market Overview

France presents a paradox for cannabis entrepreneurs: it is simultaneously the EU's largest hemp cultivator and one of its strictest countries on recreational cannabis. With over 20,000 hectares of hemp under cultivation, France has deep agricultural expertise and established supply chains for hemp fiber, seed, and derivatives. The CBD retail market emerged rapidly after regulatory shifts, though the legal landscape has been turbulent, with temporary bans on CBD flower sales overturned by courts in 2022. The medical cannabis experimental program, launched in 2021, has provided cannabis-based products to approximately 3,000 patients with serious conditions, though the program's future and potential expansion remain under discussion. France's population of 67 million represents the second-largest potential consumer market in Europe, but the political environment remains hostile to broader legalization. For entrepreneurs, the most viable opportunities currently lie in CBD retail, hemp cultivation and processing, and positioning for any eventual expansion of the medical program.

Capital Requirements

Moderate; CBD retail requires standard commercial investment, hemp cultivation requires agricultural land and equipment

Application Process

Register a French legal entity (SARL, SAS, or auto-entrepreneur) with the Centre de Formalites des Entreprises (CFE) and obtain a SIRET number.

For CBD retail, ensure all products comply with French regulations allowing CBD from EU-certified hemp varieties with less than 0.3% THC in the plant, and that finished products contain no detectable THC.

For hemp cultivation, register with FranceAgriMer and use only EU-certified seed varieties from the Common Catalogue. Notify local authorities before planting.

For participation in the medical cannabis experimental program (experimentation), apply through the ANSM (National Agency for the Safety of Medicines) as a healthcare provider or product supplier.

Maintain full compliance with evolving French regulations on CBD, including recent court rulings and MILDECA (interministerial mission) guidelines on product presentation and health claims.

Estimated timeline: 1-3 months for CBD retail; 6-12 months for hemp cultivation registration

Key Regulations

•CBD products are legal following a 2022 Council of State ruling overturning the ban on CBD flower, though regulatory details continue to evolve.
•France is the EU's largest hemp producer, with a well-established cultivation framework through FranceAgriMer.
•A medical cannabis experimental program launched in 2021 with approximately 3,000 patients, extended through 2025.
•Recreational cannabis remains strictly illegal with significant penalties, and France has Europe's strictest enforcement approach.

Opportunities

Second-largest population in Europe (67 million) creating enormous potential consumer demand for CBD products.

EU's largest hemp producer with established agricultural expertise, supply chains, and processing infrastructure.

Growing CBD market following court victories legalizing flower sales and increasing consumer awareness.

Medical cannabis experimental program could expand, creating new opportunities for authorized suppliers.

Challenges

Hostile political environment toward recreational cannabis with no legalization movement expected near-term.

Regulatory uncertainty around CBD with rules changing frequently and enforcement inconsistencies across prefectures.

Medical cannabis program remains experimental and small-scale with uncertain expansion timeline.

Strong anti-cannabis cultural sentiment in certain political and media circles creating reputational risk.

Frequently Asked Questions

Can I sell CBD flower in France?

Yes, following a January 2022 Council of State ruling that overturned the government ban on CBD flower sales. Products must come from EU-certified hemp varieties and contain less than 0.3% THC in the plant material. However, regulations continue to evolve and retailers should monitor updates closely.

Is France likely to legalize recreational cannabis?

As of 2025, recreational cannabis legalization is not on the French political agenda. Both major political blocs have opposed legalization, though a citizen consultation in 2021 showed growing public support. Business planning should focus on CBD and hemp segments for the foreseeable future.

How do I register as a hemp farmer in France?

Hemp farmers must register with FranceAgriMer, use only EU-certified seed varieties from the Common Catalogue, and notify local authorities of cultivation plans. France has a well-established hemp cultivation framework and is the EU's leading producer, making registration relatively straightforward for qualified agricultural operators.

Related Country Guides

Starting a Cannabis Business in Spain

How to start a cannabis social club or CBD business in Spain. Regional regulations, Barcelona club scene, membership rules, and legal framework for cannabis entrepreneurs.

Starting a Cannabis Business in Luxembourg

Luxembourg cannabis business guide. Planned legalization framework, home cultivation rules, CBD retail opportunities, and positioning for future commercial licensing.

Starting a Cannabis Business in Italy

Starting a cannabis light or medical cannabis business in Italy. Retail licensing, Law 242/2016, hemp cultivation rules, and pharmaceutical distribution requirements.

Explore More

All European Markets|Europe Overview|Legalization Tracker|Industry Analysis

Disclaimer: This information is for educational purposes only and does not constitute legal, financial, or business advice. Cannabis regulations in France are subject to change. Consult with qualified legal and financial professionals familiar with France's regulatory framework before starting any cannabis-related business. Cannabismarketcap does not guarantee the accuracy or completeness of any information presented.